Product Description
Product details
- Medicine type : Bendamustine
- Prescription/Non Prescription : Prescription
- Dosage Form : 100MG
- Packaging : BOX
- Brand : Bendamustine
- Manufacturer : Bendamustine
Precision Treatment for Hematological MalignanciesBendamustine Injection is specifically formulated to target chronic lymphocytic leukemia and non-Hodgkin's lymphoma. As a cytostatic antineoplastic agent, it offers an effective approach for hospitals seeking advanced cancer therapy options. Each vial delivers reliable dosing and meets stringent standards, supporting precision in treatment protocols.
Safe Administration ProtocolsTo maximize patient safety, Bendamustine Injection must only be administered intravenously by qualified healthcare professionals. The product is dispensed in single-use vials, and reconstitution is required before use. Compatibility with standard 0.9% Sodium Chloride Injection ensures straightforward preparation and accurate dosing for each patient.
Quality Assurance and StorageManufactured in India, each vial of Bendamustine Injection has a batch or lot number for traceability. The solution remains stable when stored below 25C and protected from light, supporting a shelf life of 24 months. These features ensure the product maintains efficacy and integrity throughout its storage and usage cycle.
FAQ's of Bendamustine Injection For Hospital:
Q: How should Bendamustine Injection be prepared before administration?
A: Bendamustine Injection must be reconstituted using the solvent provided in the packaging, followed by further dilution with 0.9% Sodium Chloride Injection. The process should be performed by healthcare professionals according to the hospital's protocols.
Q: What is the recommended route and method of administration for Bendamustine Injection?
A: This medication is for intravenous use only and must be administered by healthcare professionals in a hospital setting. Single-use vials should be discarded after one dose to maintain safety and sterility.
Q: When is Bendamustine Injection indicated for use?
A: Bendamustine Injection is indicated for the treatment of chronic lymphocytic leukemia and non-Hodgkin's lymphoma, providing targeted therapy for these hematological malignancies.
Q: Where can I find information on the batch or lot number of Bendamustine Injection?
A: The batch or lot number is clearly printed on the product packaging, ensuring traceability and quality assurance for each vial supplied.
Q: What are the benefits of using Bendamustine Injection for hospital oncology treatments?
A: Bendamustine's cytostatic antineoplastic properties offer an advanced approach to chemotherapy, targeting cancer cells effectively and supporting precise dosing strategies for improved patient outcomes.
Q: What storage conditions are required for Bendamustine Injection?
A: This product should be stored below 25C and protected from light to maintain efficacy and uphold its 24-month shelf life.
Q: Is Bendamustine Injection ready to use upon opening the vial?
A: No, the injection requires reconstitution with the solvent provided, then further dilution with saline, prior to intravenous administration.